“BCR ABL KINASE INHIBITORS FOR CANCER THERAPY”, Int. J. Pharm. Sci. Drug Res., vol. 2, no. 2, pp. 80–90, Apr. 2010, doi: 10.25004/IJPSDR.2010.020201.